SPG601
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPG601, covering 2025-01-14 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants [Phase 2, Phase 3]